Home › GSK raises $853 million by halving stake in South African drugmaker
 

Keywords :   


GSK raises $853 million by halving stake in South African drugmaker

2015-03-13 12:04:30| Biotech - Topix.net

GlaxoSmithKline has taken profits in Aspen Pharmacare by selling half its stake in the South African drugmaker for $853 million , following a long investment in the firm. The sale, which was conducted through a share placing at a discount to the market price, is the latest example of GSK pruning non-core investments as it refocuses its business and works to protect its sizeable dividend payments to shareholders.

Tags: south million african raises

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
04.05Weekly Recap: Sherwin-Williams, BASF, Abrafati Top This Weeks Stories
03.05'Garden floods show need to work with nature'
03.05Worst-ever job interviews: 'We had to crawl and moo'
03.05Have the wheels come off for Tesla?
03.05BW Converting focuses on time, energy and cost savings at INFOFLEX
03.05Navigator Paper Ups Offer for Accrual
03.05USDA urged to restore NASS surveys
03.05Dilo Hosts Open House
More »